SCHEMBL4452499

SCHEMBL4452499

N[C@@]12CC[C@@H](C[C@H]1C(=O)O)C2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A12 P48065 1/20 0.46
SLC6A11 P48066 1/20 0.46
GRM4 Q14833 8/20 0.41
CYP1A2 P05177 4/20 0.41
CYP2C19 P33261 3/20 0.41
GRM2 Q14416 3/20 0.41
GRM3 Q14832 3/20 0.41
ALOX15 P16050 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
GRM8 O00222 2/20 0.41
GRM6 O15303 2/20 0.41
LMNA P02545 1/20 0.41
GRM5 P41594 1/20 0.41
MTOR P42345 1/20 0.41
GRM1 Q13255 1/20 0.41
PLCB1 Q9NQ66 1/20 0.41
TSHR P16473 1/20 0.41
SLC6A4 P31645 1/20 0.40
ALDH1A1 P00352 2/20 0.38
CYP2C9 P11712 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL339517 1.00 SLC6A12 (0.46) SLC6A12SLC6A11GRM4CYP1A2CYP2C19
SCHEMBL1029829 1.00 SLC6A12 (0.46) SLC6A12SLC6A11GRM4CYP1A2CYP2C19
SCHEMBL10331842 0.88 SLC6A12 (0.44) SLC6A12SLC6A11GRM4CYP1A2CYP2C19
SCHEMBL9141620 0.73 GRM4 (0.34) SLC6A12SLC6A11GRM4CYP1A2CYP2C19
SCHEMBL22941787 0.73 GRM4 (0.34) SLC6A12SLC6A11GRM4CYP1A2CYP2C19
SCHEMBL27607943 0.73 GRM4 (0.35) SLC6A12SLC6A11GRM4CYP1A2CYP2C19
SCHEMBL3580179 0.72 SLC1A2 (0.38) GRM4CYP1A2CYP2C19GRM2GRM3
SCHEMBL76019 0.72 GRM4 (0.37) GRM4CYP1A2CYP2C19GRM2GRM3
SCHEMBL5925394 0.72 GRM2 (0.33) GRM4CYP1A2CYP2C19GRM2GRM3
SCHEMBL15440623 0.72 GRM4 (0.37) GRM4CYP1A2CYP2C19GRM2GRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009076651-A9 METHODS FOR IDENTIFYING COMPOUNDS THAT MODULATE LISCH-LIKE PROTEIN OR C1ORF32 PROTEIN ACTIVITY AND METHODS OF USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2009-08-27 WO disclosed
WO-2009076651-A2 METHODS FOR IDENTIFYING COMPOUNDS THAT MODULATE LISCH-LIKE PROTEIN OR C1ORF32 PROTEIN ACTIVITY AND METHODS OF USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2009-06-18 WO disclosed
WO-2007001399-A2 COMPOSITIONS, SPLICE VARIANTS AND METHODS RELATING TO CANCER SPECIFIC GENES AND PROTEINS DIADEXUS, INC. (US) 2007-01-04 WO disclosed
WO-2006121991-A2 COMPOSITIONS AND METHODS FOR DETECTION, PROGNOSIS AND TREATMENT OF BREAST CANCER DIADEXUS, INC. (US) 2006-11-16 WO disclosed
EP-1581641-A4 COMPOSITIONS, SPLICE VARIANTS AND METHODS RELATING TO OVARIAN SPECIFIC GENES AND PROTEINS DIADEXUS INC (US) 2006-11-15 EP disclosed
EP-1581641-A2 COMPOSITIONS, SPLICE VARIANTS AND METHODS RELATING TO OVARIAN SPECIFIC GENES AND PROTEINS Diadexus, Inc. (US) 2005-10-05 EP disclosed
WO-2005044075-A2 COMPOSITIONS, SPLICE VARIANTS AND METHODS RELATING TO BREAST SPECIFIC GENES AND PROTEINS DIADEXUS, INC. (US) 2005-05-19 WO disclosed
WO-2005044977-A2 COMPOSITIONS, SPLICE VARIANTS AND METHODS RELATING TO LUNG SPECIFIC GENES AND PROTEINS DIADEXUS, INC. (US) 2005-05-19 WO disclosed
WO-2005027713-A2 COMPOSITIONS, SPLICE VARIANTS AND METHODS RELATING TO COLON SPECIFIC GENES AND PROTEINS DIADEXUS, INC. (US) 2005-03-31 WO disclosed
WO-2005017102-A2 COMPOSITIONS, SPLICE VARIANTS AND METHODS RELATING TO OVARIAN SPECIFIC NUCLEIC ACIDS AND PROTEINS DIADEXUS, INC. (US) 2005-02-24 WO disclosed
WO-2002040535-A2 COMPOSITIONS AND METHODS RELATING TO OVARY SPECIFIC GENES AND PROTEINS DIADEXUS, INC. (US) 2002-05-23 WO disclosed
WO-2002040672-A2 COMPOSITIONS AND METHODS RELATING TO BREAST SPECIFIC GENES AND PROTEINS DIADEXUS, INC. (US) 2002-05-23 WO disclosed
WO-2002040720-A2 COMPOSITIONS AND METHODS RELATING TO OVARY SPECIFIC GENES AND PROTEINS DIADEXUS, INC. (US) 2002-05-23 WO disclosed
WO-2002039431-A2 COMPOSITIONS AND METHODS RELATING TO PROSTATE SPECIFIC GENES AND PROTEINS DIADEXUS, INC. (US) 2002-05-16 WO disclosed
WO-2002038810-A2 COMPOSITIONS AND METHODS RELATING TO PROSTATE SPECIFIC GENES AND PROTEINS DIADEXUS, INC. (US) 2002-05-16 WO disclosed
WO-2002036616-A2 COMPOSITIONS AND METHODS RELATING TO BREAST SPECIFIC GENES AND PROTEINS DIADEXUS, INC. (US) 2002-05-10 WO disclosed
WO-2002036807-A2 COMPOSITIONS AND METHODS RELATING TO BREAST SPECIFIC GENES AND PROTEINS DIADEXUS, INC. (US) 2002-05-10 WO disclosed
WO-2002036808-A2 COMPOSITIONS AND METHODS RELATING TO PROSTATE SPECIFIC GENES AND PROTEINS DIADEXUS, INC. (US) 2002-05-10 WO disclosed
WO-2002026818-A2 HUMAN NEDD-1 AEOMICA, INT. (US) 2002-04-04 WO disclosed
WO-2002024718-A1 COMPOSITIONS AND METHODS RELATING TO PROSTATE SPECIFIC GENES AND PROTEINS DIADEXUS, INC. (US) 2002-03-28 WO disclosed